CN104474439A - 一种治疗眼部炎症的中药滴眼液及其制备方法 - Google Patents
一种治疗眼部炎症的中药滴眼液及其制备方法 Download PDFInfo
- Publication number
- CN104474439A CN104474439A CN201410691234.5A CN201410691234A CN104474439A CN 104474439 A CN104474439 A CN 104474439A CN 201410691234 A CN201410691234 A CN 201410691234A CN 104474439 A CN104474439 A CN 104474439A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- traditional chinese
- chinese medicine
- eye drops
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 34
- 239000003889 eye drop Substances 0.000 title claims abstract description 18
- 229940012356 eye drops Drugs 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 206010061218 Inflammation Diseases 0.000 title abstract description 4
- 230000004054 inflammatory process Effects 0.000 title abstract description 4
- 239000000843 powder Substances 0.000 claims abstract description 16
- 229930003270 Vitamin B Natural products 0.000 claims description 16
- 235000019156 vitamin B Nutrition 0.000 claims description 16
- 239000011720 vitamin B Substances 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 244000293323 Cosmos caudatus Species 0.000 claims description 13
- 235000005956 Cosmos caudatus Nutrition 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000010231 banlangen Substances 0.000 claims description 11
- 241000628997 Flos Species 0.000 claims description 10
- 239000008517 radix Trichosanthis Substances 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 206010015943 Eye inflammation Diseases 0.000 claims description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- MMMUSDJYPJXNPH-UHFFFAOYSA-L [Hg](F)F.N#CC#N Chemical compound [Hg](F)F.N#CC#N MMMUSDJYPJXNPH-UHFFFAOYSA-L 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000004615 ingredient Substances 0.000 claims description 5
- 238000011084 recovery Methods 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 230000003204 osmotic effect Effects 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 18
- 210000004087 cornea Anatomy 0.000 abstract description 12
- 206010023332 keratitis Diseases 0.000 abstract description 9
- 230000003612 virological effect Effects 0.000 abstract description 8
- 206010010741 Conjunctivitis Diseases 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 6
- 230000001154 acute effect Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 3
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 206010010755 Conjunctivitis viral Diseases 0.000 abstract description 2
- 208000005914 Viral Conjunctivitis Diseases 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 208000030533 eye disease Diseases 0.000 abstract description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 244000059800 Amomum compactum Species 0.000 abstract 1
- 235000016426 Amomum compactum Nutrition 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000004638 Dendrobium nobile Species 0.000 abstract 1
- 241000576429 Forsythia suspensa Species 0.000 abstract 1
- 241000146384 Glaux Species 0.000 abstract 1
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 244000246386 Mentha pulegium Species 0.000 abstract 1
- 235000016257 Mentha pulegium Nutrition 0.000 abstract 1
- 235000004357 Mentha x piperita Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 229930003451 Vitamin B1 Natural products 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 201000004484 acute conjunctivitis Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 201000005547 chronic conjunctivitis Diseases 0.000 abstract 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 abstract 1
- 235000001050 hortel pimenta Nutrition 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 229960003495 thiamine Drugs 0.000 abstract 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000003901 trigeminal nerve Anatomy 0.000 abstract 1
- 235000010374 vitamin B1 Nutrition 0.000 abstract 1
- 239000011691 vitamin B1 Substances 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 210000001508 eye Anatomy 0.000 description 15
- 208000005100 Herpetic Keratitis Diseases 0.000 description 12
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 12
- 230000004438 eyesight Effects 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010068319 Oropharyngeal pain Diseases 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- 241000130764 Tinea Species 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 3
- 206010063659 Aversion Diseases 0.000 description 3
- 206010052369 Encephalitis lethargica Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 201000005505 Measles Diseases 0.000 description 3
- 241000475481 Nebula Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010047513 Vision blurred Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 210000000795 conjunctiva Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 210000001328 optic nerve Anatomy 0.000 description 3
- 231100000915 pathological change Toxicity 0.000 description 3
- 230000036285 pathological change Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 201000002498 viral encephalitis Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000003910 Baronia <angiosperm> Species 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241001523681 Dendrobium Species 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010043458 Thirst Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000005946 Xerostomia Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 210000002555 descemet membrane Anatomy 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 206010013781 dry mouth Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010014599 encephalitis Diseases 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007667 floating Methods 0.000 description 2
- 239000007850 fluorescent dye Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000000578 peripheral nerve Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-Phenylethanol Natural products OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 1
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 1
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 201000006082 Chickenpox Diseases 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010717 Conjunctival follicles Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010022941 Iridocyclitis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 102000007547 Laminin Human genes 0.000 description 1
- 108010085895 Laminin Proteins 0.000 description 1
- 241001215120 Leptospirales Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 description 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 229930183118 Tanshinone Natural products 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 206010046851 Uveitis Diseases 0.000 description 1
- 206010046980 Varicella Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 201000004612 anterior uveitis Diseases 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001742 aqueous humor Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000008335 axon cargo transport Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 201000009285 hypopyon Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 206010023365 keratopathy Diseases 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029864 nystagmus Diseases 0.000 description 1
- 206010030875 ophthalmoplegia Diseases 0.000 description 1
- 206010030899 opisthotonus Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- -1 phenethyl alcohol glycosides Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 210000003583 retinal pigment epithelium Anatomy 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000001745 uvea Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000009447 viral pathogenesis Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/428—Trichosanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明属于医药领域,涉及一种治疗眼部炎症的中药滴眼液及其制备方法,具体涉及一种治疗病毒性角膜炎、病毒性结合膜炎、急慢性结合膜炎等眼科疾病的中药滴眼液及其制备方法,按照重量份数计,包括以下药物成分:石斛20~30份、天花粉10~20份、板蓝根10~20份、连翘10~20份、珍珠粉20~30份、丹参5~8份、金银花10~15份、决明子10~20份、薄荷5~8份、生地3~5份、远志2~3份、白豆蔻2~3份、维生素B1 0.1~1份和维生素B12 0.1~1份。本发明的优点在于所使用的药物符合中华人民共和国药典规定,药物安全可靠。诸药相和具有抗炎抗过敏,营养角膜末梢三叉神经的功效,具有疗效确切、见效快、治愈率高、无副作用等特点。
Description
技术领域
本发明属于医药领域,涉及一种治疗眼部炎症的中药滴眼液及其制备方法,具体涉及一种治疗病毒性角膜炎、病毒性结合膜炎、急慢性结合膜炎等眼科疾病的中药滴眼液及其制备方法。
背景技术
病毒性角膜炎、结膜炎是一种常见的眼科疾病,由多种病毒引起,传染性极强,容易合并感染其他疾病。病毒性角膜炎是受病毒致病原感染角膜而引起的炎症。角膜浅层有丰富的三叉神经末梢,故该病常有明显的刺激症状,有畏光、流泪、酸痛等。角膜本属透明,一旦有病,则其透明度发生改变,病人常主诉有视物模糊。该病一般沿三叉神经发病,病变部位侵犯较深,其感觉减退,但因炎症刺激角膜病变的邻近组织,因此刺激症状仍较明显。病毒性角膜炎,病程牧长,愈后且易复发。常可伴有葡萄膜反应,甚至出现虹膜睫状体炎、前房积脓,或继发青光眼,是临床上较为常见的致盲眼病之一。病毒性结膜炎约经5~12天的潜伏期后出现症状,包括结膜充血,水样分泌物,眼部刺激和睡醒时上下眼睑粘住。常双眼出现症状,而通常一眼先开始。许多病人曾接触结膜炎者和/或最近患上呼吸道感染者。球结膜和睑结膜充血,睑结膜出现结膜滤泡,耳前淋巴结肿大和疼痛。临床上最常见的病毒性角膜炎、结膜炎主要有单纯疱疹性、带状疱疹性、流行性角膜炎和结膜炎等。
单纯疱疹性角膜炎,是最常见的病毒性角膜炎,其发病率较高。由于其具有易复发、迁延不愈、对药物治疗抵抗等临床特点,是主要的致盲眼病,已成为当前眼科医师最感棘手的眼病之一。
发明内容
根据以上现有技术的不足,本发明提供一种治疗眼部炎症的中药滴眼液及其制备方法,其疗效显著、安全可靠、无毒副作用,具有广阔的临床应用前景。
本发明所述的一种治疗眼部炎症的中药滴眼液,按照重量份数计,包括以下药物成分:石斛20~30份、天花粉10~20份、板蓝根10~20份、连翘10~20份、珍珠粉20~30份、丹参5~8份、金银花10~15份、决明子10~20份、薄荷5~8份、生地3~5份、远志2~3份、白豆蔻2~3份、维生素B10.1~1份和维生素B120.1~1份。
其中,优选方案如下:
按照重量份数计,包括以下药物成分:石斛25份、天花粉15份、板蓝根15份、连翘15份、珍珠粉25份、丹参6份、金银花12份、决明子15份、薄荷6份、生地4份、远志2份、白豆蔻2份、维生素B11份和维生素B121份。
本发明所述的治疗眼部炎症的中药滴眼液的制备方法,制备时,按照以下步骤进行:
(1)先将石斛、天花粉、板蓝根、连翘、珍珠粉、丹参、金银花、决明子、薄荷、生地、远志、白豆蔻加水5000毫升,文火煮沸1小时,取滤液;
(2)残渣再加水5000毫升,文火煮沸1小时后取滤液,将两次滤液合并;
(3)将上述滤液浓缩至125毫升,冷却后加375毫升质量分数为95%的乙醇混匀,放置24小时后用滤纸过滤;
(4)将滤液挥尽或回收乙醇后,加维生素B1和维生素B12粉,搅匀再加蒸馏水至1000~5000毫升得到药液;
(5)调整药液相当于质量分数为0.8~1.2%的氯化钠的渗透压,向药液中加防腐剂氰氟化汞,其中,氰氟化汞与药液的体积比为1:1500,再用质量分数为10%的氢氧化钠调PH值至7.0;
(6)最后药液经滤纸过滤,加盖密封,高压消毒,分装8毫升/支。
使用时,每天3~5次,每次1~2滴。
药理分析:
石斛:为传统中药,来源于兰科石斛,属Dendrobium多种植物的茎,性微寒。功效益胃生津、清热养阴,主治热病伤津、口干烦渴、病后虚热、阴伤目暗。石斛茎中含有多种生物碱、多糖、氨基酸及淀粉等,有一定解热镇痛作用;能促进胃液分泌,助消化;有增强新陈代谢、抗衰老等作用。中医认为,五脏六腑的精气都通过血脉上注于眼睛,而肝“开窍于目”,眼睛的生理病理与肝的阴精充盛与否关系密切。肝的阴精充盛,则眼晴明亮而炯炯有神,转动灵活,神采奕奕,人也显得精神充沛;如果阴精不足,眼晴就会黯淡无光,或两眼干涩,或视物昏花,或夜盲等。石解具有滋阴养肝的功能,故被历代医家用作养护眼睛的佳品。
天花粉:味甘、微苦,性微寒,归肺、胃经;具体功效是清热泻火,生津止渴,清肺润燥、解毒消痈等。天花粉退五脏郁热,如心火盛而舌干口燥,肺火盛而咽肿喉痹,脾火盛而口舌齿肿,痰火盛而咳嗽不宁。若肝火之胁胀走注,肾火之骨蒸烦热,或痈疽已溃未溃,而热毒不散,或五疸身目俱黄,而小水若淋若涩,是皆火热郁结所致,惟此剂能开郁结,降痰火,并能治之。又其性甘寒,善能治渴,从补药而治虚渴,从凉药而治火渴,从气药而治郁渴,从血药而治烦渴,乃治渴之要药也。
板蓝根:清热,解毒,凉血,利咽。温毒发斑;高热头痛;大头瘟疫;舌绛紫暗,烂喉丹痧;丹毒;痄腮;喉痹;疮肿、痈肿;水痘;麻疹;肝炎;流行性感冒,流脑,乙脑,肺炎,神昏吐衄,咽肿,火眼,疮疹等;可防治流行性乙型脑炎、急慢性肝炎、流行性腮腺炎、骨髓炎等。板蓝根对多种细菌有抑制作用,水浸液对枯草杆菌、金黄色葡萄球菌、八联球菌、大肠杆菌、伤寒杆菌、副伤寒杆菌、痢疾(志贺、弗氏)杆菌、肠炎杆菌等都有不同程度的抑制作用;丙酮浸出液也有类似作用,且对溶血性链球菌有效(皆用琼脂小孔平板法)。对A型脑膜炎球菌之抑菌作用与大蒜、金银花相似。对流感病毒PR8株和京科68-1株有明显抑制作用,在试管内板蓝根有杀灭钩端螺旋体的作用。
连翘:主要含苯乙醇苷类、木脂体及其苷类、五环三萜娄、挥发油类等化合物。药理研究认为其具有抗菌、抗炎、解热、镇吐、利尿强心、抗肝损、镇痛、抑制磷酸二酯酶、抗病毒、降血压、抑制弹性蛋白酶活力、抗内毒素等作用。除果实入药,具清热解毒、消结排脓之效外,药用其叶,对治疗高血压、痢疾、咽喉痛等效果较好。
珍珠粉:珍珠粉有清热解毒之效,能够清肝火。肝主目,肝火旺则目生翳,视力模糊。同时经过研究发现,珍珠粉中的硒可以强化视觉神经的传导,改善视力状况;微量元素中的锌可促进视神经的轴浆运输,改善视网膜及视网膜色素上皮细胞的代谢与功能。《中华人民共和国药典》叙述:“珍珠有明目消翳之功能,主治目生云翳”,所以很多学者都将珍珠粉成为“眼科圣药”。
丹参:含丹参酮,为强壮性通经剂,有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,月经不调,血瘀,腹痛,经痛,经闭,庙痛。对治疗冠心病有良好效果。此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎。外用又可洗漆疮。
金银花:性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
决明子:具清热明目、润肠通便的功能。生决明子长于清肝热,润肠燥。用于目赤肿痛,大便秘结。
薄荷:幼嫩茎尖可作菜食,全草又可入药,治感冒发热喉痛,头痛,目赤痛,肌肉疼痛,皮肤风疹搔痒,麻疹不透等症,此外对痈、疽、疥、癣、漆疮亦有效。薄荷含有薄荷醇,该物质可清新口气并具有多种药性,可缓解腹痛、胆囊问题如痉挛,还具有防腐杀菌、利尿、化痰、健胃和助消化等功效。
生地:有止血作用,又有抗凝血作用,还具有抗真菌作用,对须疮癣菌、石膏样小芽胞癣菌、羊毛状小芽胞癣菌及奥杜盎小芽胞癣菌等多种真菌的生长有抑制作用。
远志:苦、辛、温。归心、肾、肺经。养心血,镇惊,宁心,散痰涎。疗五痫角弓反张,惊搐,口吐痰涎,手足战摇,不省人事,缩小便,治赤白浊,膏淋,滑精不禁。
白豆蔻:味辛;性温。入肺、脾经。化湿行气;温中止呕;开胃消食。主湿阻气滞;脾胃不和;脘腹胀满;不思饮食;湿温初起;胸闷不饥;胃寒呕吐;食积不消。
维生素B1:主要存在于种子的外皮和胚芽中,如米糠和麸皮中含量很丰富,在酵母菌中含量也极丰富。瘦肉、白菜和芹菜中含量也较丰富。目前所用的维生素B1都化学合成的产品。在体内,维生素B1以辅酶形式参与糖的分解代谢,有保护神经系统的作用;还能促进肠胃蠕动,增加食欲。维生素B1是视神经及周围神经的营养来源之一,能够改善眼肌麻痹,眼球震颤和视疲劳。
维生素B12:能营养角膜的末梢神经,增强角膜末梢神经的抗病能力,促进病情的康复。
本发明的优点在于所使用的药物符合中华人民共和国药典规定,药物安全可靠。诸药相和具有抗炎抗过敏,营养角膜末梢三叉神经的功效,具有疗效确切、见效快、治愈率高、无副作用等特点。
疗效判断:
1临床资料
1.1一般资料治疗组80例单疱病毒性角膜炎病人在门诊由专人负责观察治疗(共96只眼),其中男52例,女28例;年龄5~73岁;病程2~26天,平均16.3±6.36天,96只眼中浅层单疱病毒性角膜炎62只眼,深层单疱病毒性角膜炎34只眼。
1.2中医辨证分型
1.2.1浅层单疱病毒性角膜炎(风热外袭型)病人有头痛、流泪、发热、怕风等症状,舌质红,苔薄黄,脉浮数。病变仅局限于上皮或波及角膜前1/3基质层。
1.2.2深层单疱病毒性角膜炎(肝火内炽型)病人有头胀、目赤、肋闷不适等症状,舌质红,苔黄腻,脉滑数或弦数。病变深达角膜1/2基质层或后弹力层及内皮层,包括地图样角膜溃疡、盘状角膜炎和角膜葡萄膜炎。
1.2.3恢复期单疱病毒性角膜炎(肺阴不足型)病人有目涩、视物混暗伴乏力、盗汗等症状,舌质红,少苔脉细数。病变后期,病情趋向稳定,角膜浸润明显好转恢复阶段。
2治疗方法
每天3~5次,每次1~2滴。20天一个疗程,治疗两个疗程。
2.1.6疗效标准①治愈:浅层单疱病毒性角膜炎为溃疡愈合,病灶区荧光索着色转为阴性;深层单疱病毒性角膜炎及恢复期单疱病毒性角膜炎除上述标准外,在裂隙灯切面中,基质层浸润、水肿消失,不增厚,后弹力层皱褶及房水闪光消失②好转:浅层单疱病毒性角膜炎为溃疡部分愈合,病灶缩小,残留少许荧光素着色点。深层及恢复期单疱病毒性角膜炎除上述标准外,在裂隙灯切面中,基质层浸润、水肿减轻,角膜厚度接近正常③无效:病情无改变或加重。
3治疗结果。
三组病例治疗均以20天为1个疗程,两个疗程后统计结果。治疗组总有效率为97.50%;详见下表。
典型病例介绍
陈某,男,53岁,右眼红、痛、流泪、怕风3天。检查右眼视力0.3,左眼视力1.0,发现右眼角膜颞侧有浅层树枝样浸润,荧光素染色着色,舌质红,苔薄黄,脉浮数,属风热外袭型。经本发明滴眼液治疗38天痊愈。
王某,女,32岁,左眼红、痛、流泪、怕风、怕光5天,伴眼睑轻度水肿。检查右眼视力1.0,左眼视力0.06,发现左眼角膜中央有深层地图样浸润,荧光素染色着色,舌质红,苔黄腻,脉滑数,属肝火内炽型。经本发明滴眼液治疗28天明显好转。
具体实施方式
以下结合实施例对本发明做进一步说明。
实施例1:
一种治疗眼部炎症的中药滴眼液,按照重量份数计,包括以下药物成分:石斛25份、天花粉15份、板蓝根15份、连翘15份、珍珠粉25份、丹参6份、金银花12份、决明子15份、薄荷6份、生地4份、远志2份、白豆蔻2份、维生素B11份和维生素B121份。
实施例2:
实施例1按照以下步骤制备:
(1)先将石斛、天花粉、板蓝根、连翘、珍珠粉、丹参、金银花、决明子、薄荷、生地、远志、白豆蔻加水5000毫升,文火煮沸1小时,取滤液;
(2)残渣再加水5000毫升,文火煮沸1小时后取滤液,将两次滤液合并;
(3)将上述滤液浓缩至125毫升,冷却后加375毫升质量分数为95%的乙醇混匀,放置24小时后用滤纸过滤;
(4)将滤液挥尽或回收乙醇后,加维生素B1和维生素B12粉,搅匀再加蒸馏水至1000~5000毫升得到药液;
(5)调整药液相当于质量分数为0.8~1.2%的氯化钠的渗透压,向药液中加防腐剂氰氟化汞,其中,氰氟化汞与药液的体积比为1:1500,再用质量分数为10%的氢氧化钠调PH值至7.0;
(6)最后药液经滤纸过滤,加盖密封,高压消毒,分装8毫升/支。
Claims (3)
1.一种治疗眼部炎症的中药滴眼液,其特征在于按照重量份数计,包括以下药物成分:石斛20~30份、天花粉10~20份、板蓝根10~20份、连翘10~20份、珍珠粉20~30份、丹参5~8份、金银花10~15份、决明子10~20份、薄荷5~8份、生地3~5份、远志2~3份、白豆蔻2~3份、维生素B10.1~1份和维生素B120.1~1份。
2.根据权利要求1所述的一种治疗眼部炎症的中药滴眼液,其特征在于按照重量份数计,包括以下药物成分:石斛25份、天花粉15份、板蓝根15份、连翘15份、珍珠粉25份、丹参6份、金银花12份、决明子15份、薄荷6份、生地4份、远志2份、白豆蔻2份、维生素B11份和维生素B121份。
3.一种权利要求1所述的治疗眼部炎症的中药滴眼液的制备方法,其特征在于制备时,按照以下步骤进行:
(1)先将石斛、天花粉、板蓝根、连翘、珍珠粉、丹参、金银花、决明子、薄荷、生地、远志、白豆蔻加水5000毫升,文火煮沸1小时,取滤液;
(2)残渣再加水5000毫升,文火煮沸1小时后取滤液,将两次滤液合并;
(3)将上述滤液浓缩至125毫升,冷却后加375毫升质量分数为95%的乙醇混匀,放置24小时后用滤纸过滤;
(4)将滤液挥尽或回收乙醇后,加维生素B1和维生素B12粉,搅匀再加蒸馏水至1000~5000毫升得到药液;
(5)调整药液相当于质量分数为0.8~1.2%的氯化钠的渗透压,向药液中加防腐剂氰氟化汞,其中,氰氟化汞与药液的体积比为1:1500,再用质量分数为10%的氢氧化钠调PH值至7.0;
(6)最后药液经滤纸过滤,加盖密封,高压消毒,分装8毫升/支。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410691234.5A CN104474439A (zh) | 2014-11-25 | 2014-11-25 | 一种治疗眼部炎症的中药滴眼液及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410691234.5A CN104474439A (zh) | 2014-11-25 | 2014-11-25 | 一种治疗眼部炎症的中药滴眼液及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104474439A true CN104474439A (zh) | 2015-04-01 |
Family
ID=52749140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410691234.5A Pending CN104474439A (zh) | 2014-11-25 | 2014-11-25 | 一种治疗眼部炎症的中药滴眼液及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474439A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308342A (zh) * | 2017-06-23 | 2017-11-03 | 海南诗博丽生物科技有限公司 | 一种石斛滴眼液及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638432A (zh) * | 2013-11-27 | 2014-03-19 | 许伟 | 中药眼药水 |
-
2014
- 2014-11-25 CN CN201410691234.5A patent/CN104474439A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103638432A (zh) * | 2013-11-27 | 2014-03-19 | 许伟 | 中药眼药水 |
Non-Patent Citations (1)
Title |
---|
叶丽南: "单纯疱疹性角膜炎", 《广西卫生》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107308342A (zh) * | 2017-06-23 | 2017-11-03 | 海南诗博丽生物科技有限公司 | 一种石斛滴眼液及其制备方法 |
CN107308342B (zh) * | 2017-06-23 | 2020-05-12 | 海南诗博丽生物科技有限公司 | 一种治疗细菌感染引起的眼结膜炎和角膜炎的石斛滴眼液 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101804166B (zh) | 一种治疗小儿皮炎湿疹的中药组合物 | |
CN103405728B (zh) | 一种治疗更年期综合症的中药组合物及其制备方法 | |
CN101773653B (zh) | 一种治疗目盲的中药组合物及其制备方法 | |
CN103417904A (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
CN104248716A (zh) | 复方滴眼液及其制备方法 | |
CN104606615A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN104013868A (zh) | 一种治疗慢性阻塞性肺疾病的中药组合物及其制备方法 | |
CN104173517B (zh) | 治疗原发性三叉神经痛的中药制剂及制备方法 | |
CN104587043A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN103877424B (zh) | 一种治疗沙眼的中药药水及制备方法 | |
CN103520643B (zh) | 一种用于治疗糖尿病白内障的中药制剂及其制备方法 | |
CN104474439A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN105727132A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN104623318A (zh) | 一种用于翼状胬肉的中药制剂及制备方法 | |
CN104587076A (zh) | 一种治疗结膜炎的中药洗液 | |
CN104474289A (zh) | 治疗眼部炎症的中药滴眼液及其制备方法 | |
CN105749109A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN105726984A (zh) | 治疗眼部炎症的中药滴眼液及其制备方法 | |
CN107137689A (zh) | 一种治疗更年期综合征的中药组合物 | |
CN104288306A (zh) | 一种治疗眼病的中药滴眼液及其制备方法 | |
CN104288225A (zh) | 一种治疗眼部炎症的中药滴眼液及其制备方法 | |
CN103961466A (zh) | 一种治疗干眼症的口服方剂 | |
CN104587364A (zh) | 一种治疗葡萄膜炎的中药组合物 | |
CN104721786A (zh) | 一种治疗妊娠肝内胆汁淤积症的中药制剂及其制备方法 | |
CN104524068A (zh) | 一种治疗红眼病的中药滴眼液及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
RJ01 | Rejection of invention patent application after publication |